Skip to main content

UBS Group AG

Position in RDY — Dr Reddys Laboratories Ltd

CIK 1610520 ZURICH, V8

Position in RDY

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$21,499,465
+$7,649,315 QoQ
Shares Held
1,552,308
+57.4% QoQ
Ownership
0.186%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

UBS Group AG holds $1,523,036,852 across 81 Drug Manufacturers - Specialty & Generic names. RDY ranks #15 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RDY

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $21,499,465 1,552,308
2025-12-31 $13,850,150 986,478
2025-09-30 $17,227,273 1,232,280
2025-06-30 $18,138,848 1,206,843
2025-03-31 $11,868,480 899,809
2024-12-31 $12,329,178 780,822
2024-09-30 $1,367,890 17,217
2024-06-30 $2,821,162 37,028
2024-03-31 $3,493,292 47,625
2023-12-31 $1,044,604 15,013
2023-09-30 $1,063,834 15,909
2023-06-30 $975,491 15,457
2023-03-31 $856,227 15,040
2022-12-31 $856,875 16,558
2022-09-30 $939,554 17,951
2022-06-30 $861,479 15,553
2022-03-31 $2,634,579 47,274
2021-12-31 $2,211,118 33,804
2021-09-30 $1,070,444 16,433
2021-06-30 $918,874 12,500
2021-03-31 $835,701 13,613
2020-12-31 $1,222,623 17,150
2020-09-30 $1,641,754 23,602
2020-06-30 $1,419,607 26,780
2020-03-31 $2,015,733 49,981